Fatemeh Oroojalian

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Tissue Engineering

Hyaluronic Acid

Top Venues

Nanomedicine (London, England)

Biotechnology progress

Advanced healthcare materials

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Amiri, Amir Mahdi Molavi, Amir Amani, Kurosh Hamzanlui Moqadam, Mehran Vatanchian, Seyyed Ahmad Hashemi, Fatemeh Oroojalian
Fabrication, Characterization and Wound-Healing Properties of Core-Shell SF@chitosan/ZnO/ Astragalus Arbusculinus Gum Nanofibers. Nanomedicine (London, England) 19 (6) (2024)
Zahra Amiri, Amir Mahdi Molavi, Amir Amani, Kurosh Hamzanlui Moqadam, Mehran Vatanchian, Seyyed Ahmad Hashemi, Fatemeh Oroojalian
Fabrication, characterization and wound-healing properties of core-shell SF@chitosan/ZnO/ Astragalus arbusculinus gum nanofibers. Nanomedicine (London, England) (2024)
Zahra Amiri, Amir Mahdi Molavi, Amir Amani, Kurosh Hamzanlui Moqadam, Mehran Vatanchian, Seyyed Ahmad Hashemi, Fatemeh Oroojalian
Fabrication, Characterization and Wound-Healing Properties of Core-Shell SF@chitosan/ZnO/ Astragalus Arbusculinus Gum Nanofibers. Nanomedicine (London, England) 19 (6) (2024)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) (2023)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) 18 (3) (2023)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) 18 (3) (2023)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) 18 (3) (2023)
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine (London, England) 18 (3) (2023)
Sania Ghobadi Alamdari, Abbas Alibakhshi, Miguel de la Guardia, Behzad Baradaran, Reza Mohammadzadeh, Mohammad Amini, Prashant Kesharwani, Amir Ali Mokhtarzadeh, Fatemeh Oroojalian, Amir Hossein Sahebkar
Conductive and Semiconductive Nanocomposite-Based Hydrogels for Cardiac Tissue Engineering. Advanced healthcare materials 11 (18) (2022)
Elham Pishavar, Fatemeh Oroojalian, Zahra Salmasi, Ezzat Hashemi, Maryam Hashemi
Recent advances of dendrimer in targeted delivery of drugs and genes to stem cells as cellular vehicles. Biotechnology progress 37 (4) (2021)